Nupharmisto
Product Images NDC 71331-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Nupharmisto (NDC 71331-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orange Lab, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Directions (Directions)

Directions (Directions)
This image shows a directions panel advising that children under 2 years should not use the product. It instructs consultation with a doctor for children under 12 years. For adults, it advises applying the product to the affected area up to six times daily, with instructions to clean and dry the area before application.*
FDA Label Image

Drug Facts (active)

Drug Facts (active)
Drug Facts panel showing active ingredients Lidocaine 5% and Menthol 0.7%, both listed as local anesthetics.*
FDA Label Image

How To Use It Correctly? (How To Use It Correctly)

How To Use It Correctly? (How To Use It Correctly)
Instructional text panel titled 'How to Use It Correctly?' provides step-by-step directions for applying a numbing cream, including cleaning the area, applying cream, waiting times for best results, and removing excess cream. A note recommends performing a patch test due to variability in numbness duration based on temperature and skin type.*
FDA Label Image

Inactive Ingredients (Inactive Ingredients)

Inactive Ingredients (Inactive Ingredients)
A drug facts panel listing the inactive ingredients in the product Nupharmisto by Orange Lab, Inc. The listed inactive ingredients include Di Water, Dimethyl Isosorbide, Ethylhexyl Palmitate, Hydrogenated Polydecene, Propylene Glycol, Arnica Montana Flower Extract, Helianthus Annuus (Sunflower) Seed Oil, Emu Oil, Phenoxyethanol, Sodium Polyacrylate, Trideceth-6, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Allantoin, Tocopheryl Acetate, Ethylhexylglycerin, and Tetrasodium Edta.*
FDA Label Image

Label 01 (Label 01)

Label 01 (Label 01)
Nupharmisto Lidocaine Numbing Cream packaging label for an anorectal (hemorrhoidal) cream containing 5% Lidocaine and Menthol with Emu Oil & Arnica. The label highlights maximum strength, fast action, and long-lasting formulation. It specifies a net weight of 60 g (2.1 oz) and includes child-resistant packaging. Manufactured in the USA by 3SO Warriors LLC, Harrisonville, Missouri. The box also displays drug facts, warnings, directions, and a list of inactive ingredients.*
FDA Label Image

Label 02 (Label 02)

Label 02 (Label 02)
Nupharmisto Lidocaine Numbing Cream 5% Lidocaine Anorectal Cream, 60 g (2.1 oz) in a child-resistant tube. The label highlights active ingredients lidocaine 5% and menthol 0.7% for local anesthesia, with emu oil and arnica. The packaging includes directions, storage instructions, warnings, and a list of inactive ingredients. Manufactured by Orange Lab, Inc in the USA.*
FDA Label Image

Local Anesthetic (Purpose)

Local Anesthetic (Purpose)
A section of drug facts text panel showing repeated listing of the purpose as "Local Anesthetic" on a blue background with white text.*
FDA Label Image

Uses (Uses)

Uses (Uses)
A drug facts panel section titled 'Uses' describing the product's application for temporary relief of localized discomfort, itching, pain, or burning in the perianal area related to anorectal disorders.*
FDA Label Image

Warnings (Warnings)

Warnings (Warnings)
Drug warning panel for Nupharmisto instructs that the product is for external use only, advises avoiding contact with eyes, and directs to discontinue use and consult a doctor if allergic reactions occur or symptoms persist beyond 7 days or recur shortly after clearing.*
FDA Label Image

Pregnant (If Pregnant)

Pregnant (If Pregnant)
A drug facts warning panel advising that if pregnant or breast-feeding, users should consult a health professional before use. The text is emphasized with 'If pregnant or breast-feeding' in bold italic font on a blue background.*
FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)
Warning text panel stating 'Keep out of reach of children' and advising to seek medical attention immediately in case of accidental ingestion.*
FDA Label Image

Other Information (Other Information)

Other Information (Other Information)
A text panel titled 'Other information' providing storage instructions for a pharmaceutical product: store at room temperature 59°-86°F (15°-30°C) and keep away from direct sunlight or heat.*
FDA Label Image

When Using This Product (When Using This Product)

When Using This Product (When Using This Product)
This image shows a warning and usage instruction panel for the product Nupharmisto by Orange Lab, Inc. The text advises not to exceed the recommended daily dosage unless directed by a doctor, warns against inserting the product into the rectum using fingers, medical devices, or applicators, and cautions against use if allergic to the ingredients or if the seal is broken or missing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.